Avalon GloboCare Corp.
ALBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 6.2% | 4.5% | -13.6% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 20.1% | 19% | 22.7% | 29.8% |
| R&D Expenses | $0 | $0 | $1 | $1 |
| G&A Expenses | $4 | $6 | $6 | $8 |
| SG&A Expenses | $4 | $7 | $7 | $8 |
| Sales & Mktg Exp. | $0 | $2 | $1 | $0 |
| Other Operating Expenses | $1 | $9 | $1 | $0 |
| Operating Expenses | $5 | $16 | $9 | $9 |
| Operating Income | -$5 | -$16 | -$9 | -$9 |
| % Margin | -369.6% | -1,254.6% | -731.4% | -635.1% |
| Other Income/Exp. Net | -$3 | -$1 | -$3 | -$0 |
| Pre-Tax Income | -$8 | -$17 | -$12 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$17 | -$12 | -$9 |
| % Margin | -592.7% | -1,330.5% | -992.4% | -653.5% |
| EPS | -8.44 | -1.59 | -1.36 | -1.09 |
| % Growth | -430.8% | -16.9% | -24.8% | – |
| EPS Diluted | -8.44 | -1.59 | -1.36 | -1.09 |
| Weighted Avg Shares Out | 1 | 11 | 9 | 8 |
| Weighted Avg Shares Out Dil | 1 | 11 | 9 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $4 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$15 | -$8 | -$8 |
| % Margin | -387.4% | -1,196.6% | -656.2% | -607.6% |